Vaxcyte, Inc.
PCVX NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 5, 2026
ET
EPS Est.
-2.06
EPS Actual
-1.97
Revenue Est.
$12.5M
Revenue Actual
--
Next Earnings Report
Date
Nov 3, 2026 · Tue
Time
Time TBD
Fiscal Period
FY2026 Q3
EPS Est.
-2.12
Revenue Est.
$12.5M
Company Overview
Vaxcyte, Inc. (ticker PCVX) is listed on NASDAQ with a market cap of about $9.04B. Its next earnings report (FY2026 Q3) is expected on Nov 3, 2026 (ET), Time TBD, with consensus EPS of -2.12. In the last 15 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Feb 27, 2023 → Aug 5, 2026
Feb 27, 2023Range: -2.30 ~ -0.70Aug 5, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 5, 2026 | -- | -2.06 | -1.97 | $12.5M | -- |
| May 6, 2026 | -- | -1.78 | Below forecast↓-2.30 | $12.5M | -- |
| Feb 24, 2026 | -- | -1.53 | Below forecast↓-1.80 | $18.8M | -- |
| Nov 4, 2025 | -- | -1.27 | Below forecast↓-1.56 | -- | -- |
| Aug 6, 2025 | -- | -1.12 | -1.22 | -- | -- |
| May 7, 2025 | -- | -1.02 | -1.04 | -- | -- |
| Feb 25, 2025 | -- | -1.16 | -1.02 | -- | -- |
| Nov 5, 2024 | -- | -1.10 | Above forecast↑-0.83 | -- | -- |
| Aug 6, 2024 | -- | -0.98 | -1.10 | -- | -- |
| May 8, 2024 | -- | -1.13 | Above forecast↑-0.85 | -- | -- |
| Feb 27, 2024 | -- | -0.90 | Below forecast↓-1.82 | -- | $14.4M |
| Nov 6, 2023 | -- | -0.79 | Below forecast↓-0.91 | -- | -- |
| Aug 8, 2023 | -- | -0.67 | -0.70 | -- | -- |
| May 8, 2023 | -- | -0.80 | -0.70 | -- | -- |
| Feb 27, 2023 | -- | -0.84 | -0.73 | -- | -- |
Original Filings (SEC)
10-Q2026-08-05 ↗
8-K2026-08-05 ↗
8-K2026-07-15 ↗
8-K2026-06-23 ↗
8-K2026-06-16 ↗
10-Q2026-05-06 ↗
8-K2026-05-06 ↗
8-K2026-02-24 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
